← Browse by Condition
Medical Condition
cardiogenic shock
Total Trials
8
Recruiting Now
8
Trial Phases
Various
ClinicalMetric tracks all active clinical trials for cardiogenic shock sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — cardiogenic shock Clinical Trials
How many clinical trials are currently recruiting for cardiogenic shock?
ClinicalMetric currently tracks 8 actively recruiting clinical trials for cardiogenic shock, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for cardiogenic shock?
cardiogenic shock research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a cardiogenic shock clinical trial?
Eligibility criteria for cardiogenic shock trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
2 trials
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT05426083
Recruiting
Left Ventricular Physiological Effects of Veno-Arterial Extracorporeal Membrane Oxygenation Support During Cardiogenic Shock
Enrollment
200 pts
Location
United States
Sponsor
University of Minnesota
NCT06253104
Recruiting
Changes in Skeletal Muscle Thickness in Patients With Acute Heart Failure
Enrollment
60 pts
Location
United States
Sponsor
Tufts Medical Center
NCT06081205
Recruiting
Study of Patients Admitted to a Cardiac Intensive Care Unit With Acute CardioVascular Disease
Enrollment
1,000 pts
Location
Greece
Sponsor
University Hospital, Ioannina
NCT07293923
Recruiting
Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock
Enrollment
10 pts
Location
Georgia, Israel
Sponsor
Magenta Medical Ltd.
NCT05485376
Recruiting
Pulmonary Artery Catheter in Cardiogenic Shock Trial
Enrollment
400 pts
Location
United States
Sponsor
Tufts Medical Center
NCT06662084
Recruiting
The ECMOCYP (cytochromes P450 Activity) Study
Enrollment
46 pts
Location
Switzerland
Sponsor
University Hospital, Geneva
NCT06078436
Recruiting
Pulmonary Artery Catheterization and Carvedilol Early Initiation in Cardiogenic SHOCK Due to HFrEF
Enrollment
160 pts
Location
South Korea
Sponsor
Min-Seok Kim
NCT04158479
Recruiting
China Extracorporeal Life Support Registry
Enrollment
20,000 pts
Location
China
Sponsor
Beijing Anzhen Hospital
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology